Sign inJoin waitlistJoin the waitlist

Devorah Segal

Director, Pediatric Neuro-Oncology Fellowship · NYU Grossman School of Medicine

Credentials: · · · ·

History

NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

Nephrology
2016–2018
NYU Grossman School of Medicine
2015–2016
Child Neurology
Rutgers Health
2012–2015
Pediatrics
Rutgers New Jersey Medical School
2009–2012
Icahn School of Medicine at Mount Sinai
2006–2010

Research

The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Nature Medicine · 2024 · 168 citations
Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression
Annals of Neurology · 2017 · 110 citations
Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia
Brain · 2020 · 70 citations

Mekka Garcia
7 papers · 7 as a resident
Kaleb Yohay
5 papers
Matthias Karajannis
3 papers
AF
Andrea Franson
2 papers
Cassie Kline
2 papers
Claire Miller
2 papers
Daniel DaCosta
2 papers
Daniel Landi
2 papers
Darius Ebrahimi-Fakhari
2 papers · 2 as a resident
James Bennett
2 papers
JA
Jeffrey Allen
2 papers
Jeffrey Wisoff
2 papers

Grants

Cingulum Bundle Pathophysiology in Schizophrenia
National Institute of Neurological Disorders and Stroke · F31
Contact PI · $34K · Icahn School of Medicine at Mount Sinai
2006–2010
Cingulum Bundle Pathophysiology in Schizophrenia
National Institute of Mental Health · F30
Contact PI · $68.3K · Icahn School of Medicine at Mount Sinai
2006–2009

Clinical trials

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome
Site PI · Available
Takeda
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Sub-investigator · Recruiting · Phase 2
Healx Limited
2025–2028